SCHEMBL12812496

SCHEMBL12812496

Nc1ccc(N2CCN(c3cnc4ccc(-c5ccc(NC(=O)Cc6ccccc6)cc5)cc4n3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ NR4A1 P22736 1/20 0.52
▸ NPC1 O15118 4/20 0.52
▸ RAB9A P51151 4/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ MCL1 Q07820 1/20 0.48
▸ WNT3A P56704 2/20 0.47
▸ HTR1A P08908 3/20 0.46
▸ DRD2 P14416 3/20 0.46
▸ HCAR2 Q8TDS4 1/20 0.44
▸ SLC2A1 P11166 1/20 0.44
▸ MCHR1 Q99705 1/20 0.44
▸ HTT P42858 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1443467 0.94 KMT2A (0.54) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL1443167 0.91 KMT2A (0.55) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12812507 0.91 NPC1 (0.52) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL1442495 0.90 HTR1A (0.52) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12812509 0.89 MEN1 (0.50) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL1442357 0.89 KMT2A (0.59) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL13276353 0.89 KMT2A (0.52) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL1443409 0.88 MAPT (0.56) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL1443398 0.88 HTR1A (0.54) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL1442104 0.87 SMN1; SMN2 (0.59) KMT2AMEN1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO disclosed
Send feedback